Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-01-23

Clinical Trial Update: A Study of Propranolol to Treat Kaposi Sarcoma [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating propranolol for Kaposi sarcoma; the study is currently NOT_YET_RECRUITING.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Propranolol (propranolol)

Snippet

Sponsor: AIDS Malignancy Consortium | Conditions: Kaposi Sarcoma | Phase 2 | Status: NOT_YET_RECRUITING